Abstract
Engineered organic nanoparticle (ONP)-mediated co-delivery of genes and therapeutic agents is emerging as a powerful tool in the treatment of several genetic and non-genetic disorders. The ONP-based combinatory approach provides a technological platform that delivers genes with chemo/radio/photo/immunotherapies for the prevention or treatment of disease progression.
Original language | English |
---|---|
Pages (from-to) | 1121-1124 |
Number of pages | 4 |
Journal | Trends in Biotechnology |
Volume | 35 |
Issue number | 12 |
DOIs | |
Publication status | First published - 14 Aug 2017 |
Externally published | Yes |